Opexa Therapeutics (OPXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OPXA | ALZN | SLXN | ||
| Company | Opexa Therapeutics | Alzamend Neuro Inc | Silexion Therapeutics Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.15 | 2.04 | 2.28 | ||
| High | 1.16 | 2.04 | 2.28 | ||
| Low | 0.96 | 1.90 | 2.06 | ||
| Latest | 0.97 | 1.95 | 2.08 | ||
| Change | -0.10 | -0.07 | -0.21 | ||
| % Change | -9.35% | -3.47% | -9.21% | ||
| Volume | 307,200 | 63,200 | 54,500 | ||
| 20-Day Average Volume | 233,245 | 47,090 | 47,820 | ||
| Previous Close | 1.07 | 2.02 | 2.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.93 | 2.12 | 2.67 | ||
| 20-Day Raw Stochastic | 47.22% | 12.20% | 1.61% | ||
| 20-Day Relative Strength | 54.95 | 38.19 | 33.15 | ||
| Weighted Alpha | -17.12 | -75.28 | -90.85 | ||
| Today's Opinion | N/A | 100% Sell | 100% Sell | ||
| Previous Opinion | N/A | 100% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.02% since 09/13/17 | -7.58% since 12/19/25 | -13.37% since 12/19/25 | ||
| Low | 0.96 on 09/20/17 | 1.90 on 12/29/25 | 2.06 on 12/29/25 | ||
| High | 1.16 on 09/20/17 | 2.13 on 12/23/25 | 2.54 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +29.33% since 08/18/17 | -10.96% since 11/28/25 | -26.53% since 11/28/25 | ||
| Low | 0.74 on 08/21/17 | 1.90 on 12/29/25 | 2.06 on 12/29/25 | ||
| High | 1.16 on 09/20/17 | 2.31 on 12/08/25 | 3.24 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +64.41% since 06/20/17 | -17.37% since 09/29/25 | -38.67% since 09/29/25 | ||
| Low | 0.55 on 06/22/17 | 1.88 on 11/24/25 | 2.06 on 12/29/25 | ||
| High | 1.45 on 07/05/17 | 2.68 on 10/31/25 | 4.26 on 10/03/25 | ||
| 6-Month | |||||
| %Chg | +14.12% since 03/20/17 | -32.76% since 06/27/25 | -82.65% since 06/27/25 | ||
| Low | 0.55 on 06/22/17 | 1.88 on 11/24/25 | 2.06 on 12/29/25 | ||
| High | 1.45 on 07/05/17 | 3.60 on 07/16/25 | 22.36 on 07/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,430 | 7,679 | 7,160 | ||
| Shares Outstanding, K | 7,660 | 3,802 | 3,127 | ||
| Annual Sales | 2,910,000 | 0 | 0 | ||
| Annual Net Income | -7,980,000 | -4,510,000 | -16,440,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -930,000 | -1,000,000 | -3,260,000 | ||
| 60-Month Beta | 2.05 | -0.25 | -0.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.30 on 12/09/25 | -2.88 on 11/12/25 | ||
| Latest Earnings Date | 11/13/17 | 03/09/26 | 03/17/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||